is semaglutide long acting New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists Semaglutide - Uses | Limitations

According to the UK Summary of Product Characteristics (SmPC), nausea occurred in approximately 1221% of patients receiving dulaglutide in the AWARD clinical trial programme, compared with higher rates observed with some other agents

For a comprehensive overview of all current weight loss medication options, check out our comparison of the best weight loss medications in 2026

Taking more than the recommended amount can increase the risk of an overdose

Kushner was an investigator in the STEP trials and serves on the Global and National Advisory Board for Novo Nordisk for which he receives compensation

Learn about how GLP-1 functions with Fibersol here

The LEADER trial, for example, reported similar rates of breast cancer, prostate cancer, and other malignancies between liraglutide and placebo groups